Detalles de la búsqueda
1.
Enhanced IL-9 secretion by p66Shc-deficient CLL cells modulates the chemokine landscape of the stromal microenvironment.
Blood
; 137(16): 2182-2195, 2021 04 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33181836
2.
p66Shc deficiency in CLL cells enhances PD-L1 expression and suppresses immune synapse formation.
Front Cell Dev Biol
; 12: 1297116, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38389706
3.
A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients.
Biomed Pharmacother
; 174: 116537, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38579402
4.
Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia.
Cell Death Dis
; 15(2): 144, 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38360867
5.
p66Shc Deficiency in Chronic Lymphocytic Leukemia Promotes Chemokine Receptor Expression Through the ROS-Dependent Inhibition of NF-κB.
Front Oncol
; 12: 877495, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35847884
6.
Glycerophosphoinositol Promotes Apoptosis of Chronic Lymphocytic Leukemia Cells by Enhancing Bax Expression and Activation.
Front Oncol
; 12: 835290, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35392232
7.
Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability.
Eur J Med Chem
; 238: 114409, 2022 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35551034
8.
Optimization of Organotypic Cultures of Mouse Spleen for Staining and Functional Assays.
Front Immunol
; 11: 471, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32265925
Resultados
1 -
8
de 8
1
Próxima >
>>